Lennox-Gastaut syndrome
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.
|
23329067 |
2013 |
Lennox-Gastaut syndrome
|
0.500 |
GeneticVariation
|
disease |
ORPHANET |
Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.
|
16249883 |
2006 |
Epileptic encephalopathy
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.
|
23329067 |
2013 |
Epileptic encephalopathy
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.
|
16249883 |
2006 |
Langer-Giedion Syndrome
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.
|
23329067 |
2013 |
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperactive behavior
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Over-expression of this hyperactive mutant in transgenic parasites led to a dominant negative effect causing massive cell death during amastigote differentiation, demonstrating the essential nature of MPK10 auto-inhibition for parasite viability.
|
25232945 |
2014 |
Intellectual Disability
|
0.110 |
AlteredExpression
|
group |
BEFREE |
We previously described a patient with intellectual disability (ID) and seizures (Patient 1), carrying a de novo chromosome translocation affecting the CNS-expressed MAPK10/JNK3 gene.
|
23329067 |
2013 |
Hyperactive behavior
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Intellectual Disability
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Respiratory Function Tests
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.
|
22837378 |
2012 |
Accidental Falls
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myoclonus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Personality Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Encephalopathies
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Mental deterioration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Epileptic drop attack
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Tonic - clonic seizures
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Atypical absence seizure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures, Focal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Autistic behavior
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Generalized tonic seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of brainstem morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|